Benlot, Oscar B.

HRN: 29-02-77  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
CEFTRIAXONE 1G (VIAL)
05/21/2026
05/28/2026
IV
2g
Q 24H
T/C Early Post-op Adhesions; S/P Inguinal Exploration, Bilateral, Mesh Hernioplasty (5/18/26)
Checking Initial Appropriateness 
05/21/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/21/2026
05/28/2026
IV
500mg
Q8H
T/C Early Post-op Adhesions; S/P Inguinal Exploration, Bilateral, Mesh Hernioplasty (5/18/26)
Checking Initial Appropriateness 
05/28/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/28/2026
05/28/2026
IV
4.5g
LD
Small Bowel Obstruction Sec To Post Op Adhesions; S/P ExLap, Release Of Adhesive, Enterolysis
Checking Initial Appropriateness 
05/28/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/28/2026
06/04/2026
IV
2.25g
Q8H
Small Bowel Obstruction Sec To Post Op Adhesions; S/P ExLap, Release Of Adhesive, Enterolysis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: